Part 3/9:
According to Dr. Doyle, the aggressive marketing of TRT is not just a health trend but part of a broader scheme to maintain revenue streams for pharmaceutical giants. She pointed to scientists like Dr. Shanna Swan, who studies the impacts of plastics and industrial chemicals on hormonal health, suggesting that societal and environmental factors are intentionally undermining male testosterone levels.
The real question, she posits, is whether the widespread push for TRT is a mechanism for population control or profit—a hypothesis that aligns with concerns about how industries and policymakers may prioritize corporate gains over public health.